Voltadol 140 mg medicated plaster

Voltadol is a well-known brand of medicated plasters containing Diclofenac sodico, designed for the local treatment of pain and inflammation in joints, muscles, tendons, and ligaments. The brand is part of the broader Voltarol/Voltaren family, which was originally developed by the Swiss pharmaceutical giant Ciba-Geigy (which later became Novartis).

Manufacturing for the Italian market typically takes place within European facilities, often in Italy itself. For many years, the brand was managed by a joint venture between GSK and Novartis. However, in 2022, the consumer healthcare division was spun off into an independent company called Haleon. Today, Haleon is the ultimate owner of the brand, operating as a global leader in consumer health with its headquarters in the United Kingdom. Haleon is responsible for the distribution and marketing of Voltadol across European markets including Italy.